Tekin Hasim, Lindhardt Claes, Antvorskov Julie Christine, Bager Nicolai Schou, Michaelsen Signe Regner, Areškevičiūtė Aušrinė, Vind Jonas Pordel, Kristensen Bjarne Winther, Josefsen Knud
Department of Pathology, The Bartholin Institute, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Clinical Research, Steno Diabetes Center Copenhagen, Translational Type 1 Diabetes Research, Herlev, Denmark.
Mol Imaging Biol. 2024 Dec;26(6):943-954. doi: 10.1007/s11307-024-01961-7. Epub 2024 Nov 18.
Type 1 Diabetes (T1D) pathogenesis involves immune cells infiltrating pancreatic Islets of Langerhans, leading to T cell activation, beta cell destruction, and impaired insulin production. However, infiltration has a heterogenic nature that isn't described in detail, as not all islets are infiltrated. The aim of this study was to investigate if the observed heterogeneity is coupled to differences in immune and/or dysfunctional status of islets or exocrine cells, and if specific markers could elucidate mechanistic details of T1D pathogenesis.
The GeoMx platform was used to spatially quantify protein levels in pancreatic islets and exocrine tissue in Non-Obese Diabetic (NOD) mice. The protein panel included 17 immune activity markers and nine dysfunction markers. Immunohistochemical (IHC) staining and digital image analysis was used to analyze select marker proteins.
Use of the GeoMx platform to investigate T1D was shown to be possible, as Granzyme B protein levels were found to be lower in distal islet areas when compared to proximal areas. Smooth Muscle Actin protein levels were higher in exocrine areas proximal to immune-infiltrated islets, when compared to distally located exocrine areas. Findings from GeoMx were however not observed in IHC-stained sections.
This study demonstrates that investigating T1D is possible with spatial proteomics, as the assays revealed presence of heterogenic islet areas in NOD mice, which may play a role in T1D progression and escape from immune recognition. This study highlights the potential of spatial technologies for elucidating T1D pathogenesis and future treatment strategies.
1型糖尿病(T1D)的发病机制涉及免疫细胞浸润胰岛,导致T细胞活化、β细胞破坏以及胰岛素生成受损。然而,浸润具有异质性,且尚未得到详细描述,因为并非所有胰岛都会被浸润。本研究的目的是调查观察到的异质性是否与胰岛或外分泌细胞的免疫和/或功能失调状态的差异相关,以及特定标志物是否能够阐明T1D发病机制的细节。
使用GeoMx平台对非肥胖糖尿病(NOD)小鼠的胰岛和外分泌组织中的蛋白质水平进行空间定量。蛋白质组包括17种免疫活性标志物和9种功能失调标志物。采用免疫组织化学(IHC)染色和数字图像分析来分析选定的标志物蛋白。
研究表明,使用GeoMx平台研究T1D是可行的,因为与近端区域相比,发现颗粒酶B蛋白水平在胰岛远端区域较低。与远端外分泌区域相比,在免疫浸润胰岛近端的外分泌区域,平滑肌肌动蛋白蛋白水平较高。然而,在IHC染色切片中未观察到GeoMx的研究结果。
本研究表明,利用空间蛋白质组学研究T1D是可行的,因为检测揭示了NOD小鼠中存在异质性胰岛区域,这可能在T1D进展和逃避免疫识别中发挥作用。本研究突出了空间技术在阐明T1D发病机制和未来治疗策略方面的潜力。